LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma
Clinical trial NCT06090162 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06090162
- Sponsor
- Swiss Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2026-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.